Literature DB >> 28945717

MicroRNAs: Clinical Trials and Potential Applications
.

Nilesh Kalariya1, Kelly Brassil1, George Calin1.   

Abstract

MicroRNAs are novel biomolecules with a crucial function in normal cellular physiology and in pathophysiologic conditions, including cancer. Since the first report on the link between microRNAs and cancer was published in 2002, research has revealed the potential clinical implications of microRNAs. Oncology nurses play an important role in educating patients and their families about possible applications of microRNAs in oncology.
.

Entities:  

Keywords:  biomarkers; microRNA-based clinical trials; microRNA-based therapeutics
; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 28945717     DOI: 10.1188/17.CJON.554-559

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  2 in total

1.  The miR-223/nuclear factor I-A axis regulates inflammation and cellular functions in intestinal tissues with necrotizing enterocolitis.

Authors:  Yu Zheng Wu; Kathy Yuen Yee Chan; Kam Tong Leung; Hugh Simon Lam; Yuk Him Tam; Kim Hung Lee; Karen Li; Pak Cheung Ng
Journal:  FEBS Open Bio       Date:  2021-06-01       Impact factor: 2.693

2.  MicroRNA-133a impairs perfusion recovery after hindlimb ischemia in diabetic mice.

Authors:  Lingdan Chen; Chunli Liu; Dejun Sun; Tao Wang; Li Zhao; Wenli Chen; Mingjie Yuan; Jian Wang; Wenju Lu
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.